22/10/2026
Introducing our Depression Severity Assessment Technology
PRECISION PSYCHIATRY starts before the first prescription.
Today, we’re introducing Neomente’s AI-powered technology for depression severity assessment.
Using multimodal AI, our platform analyzes structured psychiatric interviews and generates item-level assessments based on the 17-item Hamilton Depression Rating Scale (HAM-D17), with clinicians remaining in control.
Why does severity matter? It helps guide treatment decisions, from psychotherapy for less severe cases to antidepressants, psychotherapy, or both for more severe depression.
Tracking severity over time is equally essential to assess treatment response and clinical outcomes.
This capability complements neomente ‘s clinical decision support system for personalized pharmacological treatment selection, connecting three fundamental questions:
How severe is the depression? Which treatment is most appropriate? Is it working?
Currently undergoing clinical validation, the technology may also have applications in CNS clinical trials.
More to come soon.
Dr. Ricardo Marcelo Corral Alicia Lischinsky María Gabriela Nielsen Ariel Angel Yahia Douglas Albrecht